During the past decade, Queen Elizabeth Central Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Central Hospital" #1 sponsor was "William Marsh Rice University" with 4 trials, followed by "Kamuzu University of Health Sciences" with 3 trials sponsored, "University of Oxford" with 2 trials sponsored, "University of Rochester" with 2 trials sponsored and "Boston University" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Central Hospital" #1 collaborator was "Kamuzu University of Health Sciences" with 4 trials as a collaborator, "University of Malawi" with 4 trials as a collaborator, "International Centre for Diarrhoeal Disease Research, Bangladesh" with 2 trials as a collaborator, "KEMRI-Wellcome Trust Collaborative Research Program" with 2 trials as a collaborator and "Kenya Medical Research Institute" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Central Hospital" are "Cerebral Malaria" (2 trials), "Epilepsy" (2 trials), "HIV" (2 trials), "Malaria, Cerebral" (2 trials) and "Seizure" (2 trials). Many other conditions were trialed in "Queen Elizabeth Central Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Central Hospital" are "Drug" (13 trials), "Other" (5 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "6-diazo-5-oxo-L-norleucine (DON)" (1 trials), "8 hourly LPV/r during TB treatment" (1 trials), "Artesunate" (1 trials) and "BiliSpec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Central Hospital" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Queen Elizabeth Central Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Queen Elizabeth Central Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Central Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".